Chunliu Pan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Chunliu Pan has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Jang-Yen Wu
Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL, 33431, USA.
6 shared publications - Howard Prentice
Florida Atlantic University
5 shared publications - Allison L. Price
JFK Medical Center and Division of General Internal Medicine, Miller School of Medicine, University of Miami, Miami, FL 33136, USA
1 shared publication - Amit Gupta
College of Biomedical Science, Florida Atlantic University, Boca Raton, FL 33431, USA
1 shared publication - Grace S Giraldo
Department of Biomedical Science, Florida Atlantic University, Boca Raton, FL 33431, USA
1 shared publication Howard Prentice
1 shared publication
Latest Publications
- 10 January 2013
- Published by Springer Nature
- Vol. 776, 241-258
The Mechanism of Taurine Protection Against Endoplasmic Reticulum Stress in an Animal Stroke Model of Cerebral Artery Occlusion and Stroke-Related Conditions in Primary Neuronal Cell Culture
Taurine is an inhibitory neurotransmitter and is one of the most abundant amino acids present in the mammalian nervous system. Taurine has been shown to provide protection against neurological diseases, such as Huntington’s disease, Alzheimer’s disease, and stroke. Ischemic stroke is one of the leading causes of death and disability in the world. It is generally believed that ischemia-induced brain injury is largely due to excessive release of glutamate resulting in excitotoxicity and cell death. Despite extensive research, there are still no effective interventions for stroke. Recently, we have shown that taurine can provide effective protection against endoplasmic reticulum (ER) stress induced by excitotoxicity or oxidative stress in PC12 cell line or primary neuronal cell cultures. In this study, we employed hypoxia/reoxygenation conditions for primary cortical neuronal cell cultures as an in vitro model of stroke as well as the in vivo model of rat focal middle cerebral artery occlusion (MCAO). Our data showed that when primary neuronal cultures were first subjected to hypoxic conditions (0.3%, 24 h) followed by reoxygenation (21%, 24–48 h), the cell viability was greatly reduced. In the animal model of stroke (MCAO), we found that 2 h ischemia followed by 4 days reperfusion resulted in an infarct of 47.42 ± 9.86% in sections 6 mm from the frontal pole. Using taurine greatly increased cell viability in primary neuronal cell culture and decreased the infarct area of sections at 6 mm to 26.76 ± 6.91% in the MCAO model. Furthermore, levels of the ER stress protein markers GRP78, caspase-12, CHOP, and p-IRE-1 which were markedly increased in both the in vitro and in vivo models significantly declined after taurine administration, suggesting that taurine may exert neuroprotection functions in both models. Moreover, taurine could downregulate the ratio of cleaved ATF6 and full-length ATF6 in both models. In the animal model of stroke, taurine induced an upregulation of the Bcl-2/Bax ratio and downregulation of caspase-3 protein activity indicating that it attenuates apoptosis in the core of the ischemic infarct. Our results show not only taurine elicits neuroprotection through the activation of the ATF6 and the IRE1 pathways, but also it can reduce apoptosis in these models.
- 10 January 2013
- Published by Springer Nature
- Vol. 776, 241-258
The Mechanism of Taurine Protection Against Endoplasmic Reticulum Stress in an Animal Stroke Model of Cerebral Artery Occlusion and Stroke-Related Conditions in Primary Neuronal Cell Culture
Taurine is an inhibitory neurotransmitter and is one of the most abundant amino acids present in the mammalian nervous system. Taurine has been shown to provide protection against neurological diseases, such as Huntington’s disease, Alzheimer’s disease, and stroke. Ischemic stroke is one of the leading causes of death and disability in the world. It is generally believed that ischemia-induced brain injury is largely due to excessive release of glutamate resulting in excitotoxicity and cell death. Despite extensive research, there are still no effective interventions for stroke. Recently, we have shown that taurine can provide effective protection against endoplasmic reticulum (ER) stress induced by excitotoxicity or oxidative stress in PC12 cell line or primary neuronal cell cultures. In this study, we employed hypoxia/reoxygenation conditions for primary cortical neuronal cell cultures as an in vitro model of stroke as well as the in vivo model of rat focal middle cerebral artery occlusion (MCAO). Our data showed that when primary neuronal cultures were first subjected to hypoxic conditions (0.3%, 24 h) followed by reoxygenation (21%, 24–48 h), the cell viability was greatly reduced. In the animal model of stroke (MCAO), we found that 2 h ischemia followed by 4 days reperfusion resulted in an infarct of 47.42 ± 9.86% in sections 6 mm from the frontal pole. Using taurine greatly increased cell viability in primary neuronal cell culture and decreased the infarct area of sections at 6 mm to 26.76 ± 6.91% in the MCAO model. Furthermore, levels of the ER stress protein markers GRP78, caspase-12, CHOP, and p-IRE-1 which were markedly increased in both the in vitro and in vivo models significantly declined after taurine administration, suggesting that taurine may exert neuroprotection functions in both models. Moreover, taurine could downregulate the ratio of cleaved ATF6 and full-length ATF6 in both models. In the animal model of stroke, taurine induced an upregulation of the Bcl-2/Bax ratio and downregulation of caspase-3 protein activity indicating that it attenuates apoptosis in the core of the ischemic infarct. Our results show not only taurine elicits neuroprotection through the activation of the ATF6 and the IRE1 pathways, but also it can reduce apoptosis in these models.
- 1 January 2013
- Published by Society of Adaptive Science in Taiwan in Adaptive Medicine
- Vol. 5 (1)
Multi-Faceted Role of Taurine in the Central Nervous System
Taurine has many physiological functions in the central nervous system (CNS) such as maintaining the structural integrity of the membrane, in regulating calcium binding and transport, as an osmolyte, as a neurotransmitter and neuromodulator. Taurine also can serve as a trophic factor in the development of the CNS and a neuroprotective agent in glutamate-induced neuronal injury and H2O2-induced cell injury in PC12 cell cultures. In this review, we will describe taurine's multiple-faceted role in the CNS. Particular attention is paid to the most current developments regarding to the modes of taurine function in developing and adult brains and the related neuroprotective mechanisms of taurine's actions in the CNS.
- 1 January 2013
- Published by Society of Adaptive Science in Taiwan in Adaptive Medicine
- Vol. 5 (1)
Multi-Faceted Role of Taurine in the Central Nervous System
Taurine has many physiological functions in the central nervous system (CNS) such as maintaining the structural integrity of the membrane, in regulating calcium binding and transport, as an osmolyte, as a neurotransmitter and neuromodulator. Taurine also can serve as a trophic factor in the development of the CNS and a neuroprotective agent in glutamate-induced neuronal injury and H2O2-induced cell injury in PC12 cell cultures. In this review, we will describe taurine's multiple-faceted role in the CNS. Particular attention is paid to the most current developments regarding to the modes of taurine function in developing and adult brains and the related neuroprotective mechanisms of taurine's actions in the CNS.
- 19 August 2012
- Published by Springer Nature in Amino Acids
- Vol. 46 (1) , 31-46
Taurine and central nervous system disorders
In the present era, investigators seek to find therapeutic interventions that are multifaceted in their mode of action. Such targets provide the most advantageous routes for addressing the multiplicity of pathophysiological avenues that lead to neuronal dysfunction and death observed in neurological disorders and neurodegenerative diseases. Taurine, an endogenous amino acid, exhibits a plethora of physiological functions in the central nervous system. In this review, we describe the mode of action of taurine and its clinical application in the neurological diseases: Alzheimer’s disease, Parkinson’s disease and Huntington’s disease.
- 19 August 2012
- Published by Springer Nature in Amino Acids
- Vol. 46 (1) , 31-46
Taurine and central nervous system disorders
In the present era, investigators seek to find therapeutic interventions that are multifaceted in their mode of action. Such targets provide the most advantageous routes for addressing the multiplicity of pathophysiological avenues that lead to neuronal dysfunction and death observed in neurological disorders and neurodegenerative diseases. Taurine, an endogenous amino acid, exhibits a plethora of physiological functions in the central nervous system. In this review, we describe the mode of action of taurine and its clinical application in the neurological diseases: Alzheimer’s disease, Parkinson’s disease and Huntington’s disease.
- 13 November 2011
- Published by Springer Nature in Amino Acids
- Vol. 43 (2) , 845-855
Beneficial effect of taurine on hypoxia- and glutamate-induced endoplasmic reticulum stress pathways in primary neuronal culture
Stroke (hypoxia) is one of the leading causes of mortality in the developed countries, and it can induce excessive glutamate release and endoplasmic reticulum (ER) stress. Taurine, as a free amino acid, present in high concentrations in a range of organs in mammals, can provide protection against multiple neurological diseases. Here, we present a study to investigate the potential protective benefits of taurine against ER stress induced by glutamate and hypoxia/reoxygenation in primary cortical neuronal cultures. We found that taurine suppresses the up-regulation of caspase-12 and GADD153/CHOP induced by hypoxia/reoxygenation, suggesting that taurine may exert a protective function against hypoxia/reoxygenation by reducing the ER stress. Moreover, taurine can down-regulate the ratio of cleaved ATF6 and full length ATF6, and p-IRE1 expression, indicating that taurine inhibits the ER stress induced by hypoxia/reoxygenation and glutamate through suppressing ATF6 and IRE1 pathways.
- 13 November 2011
- Published by Springer Nature in Amino Acids
- Vol. 43 (2) , 845-855
Beneficial effect of taurine on hypoxia- and glutamate-induced endoplasmic reticulum stress pathways in primary neuronal culture
Stroke (hypoxia) is one of the leading causes of mortality in the developed countries, and it can induce excessive glutamate release and endoplasmic reticulum (ER) stress. Taurine, as a free amino acid, present in high concentrations in a range of organs in mammals, can provide protection against multiple neurological diseases. Here, we present a study to investigate the potential protective benefits of taurine against ER stress induced by glutamate and hypoxia/reoxygenation in primary cortical neuronal cultures. We found that taurine suppresses the up-regulation of caspase-12 and GADD153/CHOP induced by hypoxia/reoxygenation, suggesting that taurine may exert a protective function against hypoxia/reoxygenation by reducing the ER stress. Moreover, taurine can down-regulate the ratio of cleaved ATF6 and full length ATF6, and p-IRE1 expression, indicating that taurine inhibits the ER stress induced by hypoxia/reoxygenation and glutamate through suppressing ATF6 and IRE1 pathways.
- Open Access
- 1 January 2010
- Published by Springer Nature in Journal of Biomedical Science
- Vol. 17 (Suppl 1) , S18
Protection of taurine and granulocyte colony-stimulating factor against excitotoxicity induced by glutamate in primary cortical neurons
Both taurine, an inhibitory neurotransmitter and granulocyte colony-stimulating factor (G-CSF), a growth factor, possess neuroprotective and neurotrophic properties in vitro. However, the mechanisms of their underlying neuroprotective effects are not fully understood.
- 1 January 2010
- Published by Springer Nature in Journal of Biomedical Science
- Vol. 17 (Suppl 1) , S18
Open AccessProtection of taurine and granulocyte colony-stimulating factor against excitotoxicity induced by glutamate in primary cortical neurons
Both taurine, an inhibitory neurotransmitter and granulocyte colony-stimulating factor (G-CSF), a growth factor, possess neuroprotective and neurotrophic properties in vitro. However, the mechanisms of their underlying neuroprotective effects are not fully understood.
- Open Access
- 1 January 2010
- Published by Springer Nature in Journal of Biomedical Science
- Vol. 17 (Suppl 1) , S17
Taurine protection of PC12 cells against endoplasmic reticulum stress induced by oxidative stress
Taurine is a free amino acid present in high concentrations in a variety of organs of mammalians. As an antioxidant, taurine has been found to protect cells against oxidative stress, but the underlying mechanism is still unclear.
- 1 January 2010
- Published by Springer Nature in Journal of Biomedical Science
- Vol. 17 (Suppl 1) , S17
Open AccessTaurine protection of PC12 cells against endoplasmic reticulum stress induced by oxidative stress
Taurine is a free amino acid present in high concentrations in a variety of organs of mammalians. As an antioxidant, taurine has been found to protect cells against oxidative stress, but the underlying mechanism is still unclear.